Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

Similar articles for PubMed (Select 3022745)

1.
2.

14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.

Bidlack JM, Frey DK, Seyed-Mozaffari A, Archer S.

Biochemistry. 1989 May 16;28(10):4333-9.

PMID:
2548575
3.

Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.

Nishimura SL, Recht LD, Pasternak GW.

Mol Pharmacol. 1984 Jan;25(1):29-37.

PMID:
6323950
4.

Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).

Ward SJ, Fries DS, Larson DL, Portoghese PS, Takemori AE.

Eur J Pharmacol. 1985 Jan 8;107(3):323-30.

PMID:
2984010
5.

Effects of beta-funaltrexamine on radiolabeled opioid binding.

Recht LD, Pasternak GW.

Eur J Pharmacol. 1987 Aug 11;140(2):209-14.

PMID:
2822439
6.

3H-dihydromorphine binding sites in subcellular fractions of rat striatum.

Antkiewicz-Michaluk L, Vetulani J, Havemann U, Kuschinsky K.

Pol J Pharmacol Pharm. 1982;34(1-3):73-8.

PMID:
6300816
7.

Reconstitution of high-affinity opioid agonist binding in brain membranes.

Remmers AE, Medzihradsky F.

Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2171-5.

8.

Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.

Antkiewicz-Michaluk L, Havemann U, Vetulani J, Wellstein A, Kuschinsky K.

Life Sci. 1984 Jul 23;35(4):347-55.

PMID:
6087059
9.
10.

Heterogeneity of opioid receptor binding in brain slices.

Barchfeld-Rothschild CC, Medzihradsky F.

J Neurosci Res. 1987;18(2):358-65.

PMID:
2891857
11.

Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone.

Bidlack JM, Frey DK, Kaplan RA, Seyed-Mozaffari A, Archer S.

Mol Pharmacol. 1990 Jan;37(1):50-9.

PMID:
1688995
12.

Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.

Liu-Chen LY, Yang HH, Li S, Adams JU.

J Pharmacol Exp Ther. 1995 Jun;273(3):1047-56.

PMID:
7791074
13.

Binding characteristics of mu and kappa agonists in rat brain subcellular fractions.

Monferini E, Adler MW, Simon EJ.

Life Sci. 1982 Sep 20-27;31(12-13):1295-8.

PMID:
6128655
14.

Differential regulation of mu-opiate receptors in heroin- and morphine-dependent rats.

Bolger GT, Skolnick P, Rice KC, Weissman BA.

FEBS Lett. 1988 Jul 4;234(1):22-6.

15.

Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin.

James IF, Chavkin C, Goldstein A.

Proc Natl Acad Sci U S A. 1982 Dec;79(23):7570-4.

16.

The binding of kappa- and sigma-opiates in rat brain.

Wolozin BL, Nishimura S, Pasternak GW.

J Neurosci. 1982 Jun;2(6):708-13.

17.

Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.

Reddy PL, Veeranna, Matwyshyn GA, Thorat SN, Bhargava HN.

Gen Pharmacol. 1994 Mar;25(2):355-61.

PMID:
8026736
18.

Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites.

Airaksinen MM, Mikkonen E.

Med Biol. 1980 Dec;58(6):341-4.

PMID:
6112290
19.

Opiate receptor characteristics in brains from young, mature and aged mice.

Ueno E, Liu DD, Ho IK, Hoskins B.

Neurobiol Aging. 1988 May-Jun;9(3):279-83.

PMID:
2840590
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk